A股異動 | 天華超淨(300390.SZ)再創新高 擬25億投建電池級氫氧化鋰生產線
格隆匯9月3日丨天華超淨(300390.SZ)跳空高開,盤初一度拉昇漲超11%,高見119元再創歷史新高價,總市值達450億元。天華超淨2日晚公吿,擬與甘眉工業園區擬簽訂項目投資合同,建設年產6萬噸電池級氫氧化鋰生產線及相關生產設施、配套設施,項目預計總投資25億元。另外,日前公司與四川省宜賓市江安縣人民政府擬簽訂項目投資協議書,擬投資23億元建年產5萬噸新能源鋰電材料項目。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.